日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Selective anti-CXCR2 receptor blockade by AZD5069 inhibits CXCL8-mediated pro-tumorigenic activity in human thyroid cancer cells in vitro.

AZD5069 选择性阻断 CXCR2 受体,可抑制体外人甲状腺癌细胞中 CXCL8 介导的促肿瘤活性

Coperchini F, Greco A, Petrosino E, Croce L, Teliti M, Marchesi N, Pascale A, Calì B, Pignatti P, Magri F, Uddin M, Rotondi M

Cardiovascular and metabolic comorbidities in patients with thyroid nodules: the impact of incidental diagnosis

甲状腺结节患者的心血管和代谢合并症:偶然诊断的影响

Croce, L; Ruggeri, R M; Cappelli, C; Virili, C; Coperchini, F; Laganà, M; Costa, P; Dal Molin, M; Chytiris, S; Magri, F; Chiovato, L; Centanni, M; Cannavò, S; Rotondi, M

Changing the structure of PFOA and PFOS: a chemical industry strategy or a solution to avoid thyroid-disrupting effects?

改变 PFOA 和 PFOS 的结构:是化学工业的策略,还是避免甲状腺干扰作用的解决方案?

Coperchini, F; Greco, A; Rotondi, M

Vitamin D and interferon-γ co-operate to increase the ACE-2 receptor expression in primary cultures of human thyroid cells

维生素D和干扰素-γ协同作用,增加人甲状腺细胞原代培养物中ACE-2受体的表达。

Coperchini, F; Greco, A; Denegri, M; Ripepi, F A; Grillini, B; Bertini, J; Calì, B; Villani, L; Magri, F; Croce, L; Gaetano, C; Cappelli, C; Trimboli, P; Chiovato, L; Rotondi, M

Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis

在甲状腺细胞中检测到SARS-CoV-2受体ACE-2 mRNA:COVID-19相关亚急性甲状腺炎的线索

Rotondi, M; Coperchini, F; Ricci, G; Denegri, M; Croce, L; Ngnitejeu, S T; Villani, L; Magri, F; Latrofa, F; Chiovato, L

The new generation PFAS C6O4 does not produce adverse effects on thyroid cells in vitro

新一代 PFAS C6O4 在体外实验中不会对甲状腺细胞产生不良影响。

Coperchini, F; Croce, L; Pignatti, P; Ricci, G; Gangemi, D; Magri, F; Imbriani, M; Rotondi, M; Chiovato, L